Verheggen BG - Search Results

1

Fingolimod reduces direct medical costs compared to natalizumab in patients with relapsing-remitting multiple sclerosis in The Netherlands.

Heisen M, Treur MJ, van der Hel WS, Frequin ST, Groot MT, Verheggen BG. Heisen M, et al. Among authors: verheggen bg. J Med Econ. 2012;15(6):1149-58. doi: 10.3111/13696998.2012.707631. Epub 2012 Jul 27. J Med Econ. 2012. PMID: 22737996 Free article.

2

Estimating the quality-of-life impact and cost-effectiveness of alpha-blocker and anti-muscarinic combination treatment in men with lower urinary tract symptoms related to benign prostatic hyperplasia and overactive bladder.

Verheggen BG, Lee R, Lieuw On MM, Treur MJ, Botteman MF, Kaplan SA, Trocio JN. Verheggen BG, et al. J Med Econ. 2012;15(3):586-600. doi: 10.3111/13696998.2012.666511. Epub 2012 Feb 24. J Med Econ. 2012. PMID: 22332704 Free article.

3

Patient and physician preferences for oral pharmacotherapy for overactive bladder: two discrete choice experiments.

Heisen M, Baeten SA, Verheggen BG, Stoelzel M, Hakimi Z, Ridder A, van Maanen R, Stolk EA. Heisen M, et al. Among authors: verheggen bg. Curr Med Res Opin. 2016;32(4):787-96. doi: 10.1185/03007995.2016.1142959. Epub 2016 Feb 12. Curr Med Res Opin. 2016. PMID: 26789823

4

Cost-effectiveness of 3-year vs 1-year adjuvant therapy with imatinib in patients with high risk of gastrointestinal stromal tumour recurrence in the Netherlands; a modelling study alongside the SSGXVIII/AIO trial.

Majer IM, Gelderblom H, van den Hout WB, Gray E, Verheggen BG. Majer IM, et al. Among authors: verheggen bg. J Med Econ. 2013 Sep;16(9):1106-19. doi: 10.3111/13696998.2013.819357. Epub 2013 Jul 19. J Med Econ. 2013. PMID: 23808902 Free article. Clinical Trial.

5

Cost effectiveness analysis of immunotherapy in patients with grass pollen allergic rhinoconjunctivitis in Germany.

Westerhout KY, Verheggen BG, Schreder CH, Augustin M. Westerhout KY, et al. Among authors: verheggen bg. J Med Econ. 2012;15(5):906-17. doi: 10.3111/13696998.2012.688904. Epub 2012 May 24. J Med Econ. 2012. PMID: 22533527 Free article.

6

Cost-effectiveness analysis of exenatide once-weekly versus dulaglutide, liraglutide, and lixisenatide for the treatment of type 2 diabetes mellitus: an analysis from the UK NHS perspective.

Chuang LH, Verheggen BG, Charokopou M, Gibson D, Grandy S, Kartman B. Chuang LH, et al. Among authors: verheggen bg. J Med Econ. 2016 Dec;19(12):1127-1134. doi: 10.1080/13696998.2016.1203329. Epub 2016 Jun 28. J Med Econ. 2016. PMID: 27310712 Free article.

7

Clinical implications and cost-effectiveness analysis of rivaroxaban in patients with coronary artery disease or peripheral arterial disease in the Netherlands.

Spoorendonk JA, Briere JB, Bowrin K, Millier A, Coppens M, Tempelaar S, Verheggen B. Spoorendonk JA, et al. J Med Econ. 2021 Jan-Dec;24(1):1231-1239. doi: 10.1080/13696998.2021.1997024. J Med Econ. 2021. PMID: 34749569 Free article. Clinical Trial.

8

Economic evaluation of primary prevention of cardiovascular diseases in mild hypertension: a scenario analysis for the Netherlands.

Stevanović J, O'Prinsen AC, Verheggen BG, Schuiling-Veninga N, Postma MJ, Pechlivanoglou P. Stevanović J, et al. Among authors: verheggen bg. Clin Ther. 2014 Mar 1;36(3):368-84.e5. doi: 10.1016/j.clinthera.2014.01.008. Epub 2014 Feb 15. Clin Ther. 2014. PMID: 24534654

9

Health economic comparison of SLIT allergen and SCIT allergoid immunotherapy in patients with seasonal grass-allergic rhinoconjunctivitis in Germany.

Verheggen BG, Westerhout KY, Schreder CH, Augustin M. Verheggen BG, et al. Clin Transl Allergy. 2015 Jan 21;5:1. doi: 10.1186/s13601-015-0045-z. eCollection 2015. Clin Transl Allergy. 2015. PMID: 25691953 Free PMC article.

10

Cost-Effectiveness of Partially Hydrolyzed Whey Protein Formula in the Primary Prevention of Atopic Dermatitis in At-Risk Urban Filipino Infants.

Bhanegaonkar AJ, Horodniceanu EG, Gonzalez RRH, Canlas Dizon MV, Detzel P, Erdogan-Ciftci E, Verheggen B, Botteman MF. Bhanegaonkar AJ, et al. Value Health Reg Issues. 2014 May;3:124-135. doi: 10.1016/j.vhri.2014.04.001. Epub 2014 May 20. Value Health Reg Issues. 2014. PMID: 29702918 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

24 results

Search Page

Filters